newsfilter
← Latest News
PR Newswire·

Q BioMed Announces Initial $500k Order of Strontium89 to Chinese Market

NEW YORK, March 7, 2022 /PRNewswire/ -- Q BioMed Inc. (OTCQB:QBIO), a commercial stage biotech company, announced today that it has received a confirmed $500,000 order for Strontium Chloride USP Injections under a recently inked supply contract between